<code id='E62FF7EA27'></code><style id='E62FF7EA27'></style>
    • <acronym id='E62FF7EA27'></acronym>
      <center id='E62FF7EA27'><center id='E62FF7EA27'><tfoot id='E62FF7EA27'></tfoot></center><abbr id='E62FF7EA27'><dir id='E62FF7EA27'><tfoot id='E62FF7EA27'></tfoot><noframes id='E62FF7EA27'>

    • <optgroup id='E62FF7EA27'><strike id='E62FF7EA27'><sup id='E62FF7EA27'></sup></strike><code id='E62FF7EA27'></code></optgroup>
        1. <b id='E62FF7EA27'><label id='E62FF7EA27'><select id='E62FF7EA27'><dt id='E62FF7EA27'><span id='E62FF7EA27'></span></dt></select></label></b><u id='E62FF7EA27'></u>
          <i id='E62FF7EA27'><strike id='E62FF7EA27'><tt id='E62FF7EA27'><pre id='E62FF7EA27'></pre></tt></strike></i>

          entertainment

          entertainment

          author:focus    Page View:5
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more
          In Spain, a hospital brews its own CAR
          In Spain, a hospital brews its own CAR

          MikeReddyforSTATBARCELONA,Spain—Someofthepatientswaitingintheoncologywardofahospitalhere,withitsgree

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Keeping primary care docs in field isn't impossible, says AAFP CEO

          R.ShawnMartin,theCEOoftheAmericanAcademyofFamilyPhysiciansCourtesyAmericanAcademyofFamilyPhysiciansI